Short answer · Medically reviewed summary · Last updated: 2026-04-07
Glycogen Storage Disease (GSD) refers to a group of rare metabolic disorders caused by genetic defects that prevent the body from properly converting glycogen into glucose or storing it. Because GSD comprises at least 14 distinct subtypes, it is often referred to by the specific enzyme deficiency involved, such as von Gierke disease (GSD Type I) or Pompe disease (GSD Type II), rather than just the umbrella term. Why does Glycogen Storage Disease have so many names? The complexity of Glycogen Storage Disease nomenclature arises from how these conditions were historically discovered.
Glycogen Storage Disease (GSD) refers to a group of rare metabolic disorders caused by genetic defects that prevent the body from properly converting glycogen into glucose or storing it. Because GSD comprises at least 14 distinct subtypes, it is often referred to by the specific enzyme deficiency involved, such as von Gierke disease (GSD Type I) or Pompe disease (GSD Type II), rather than just the umbrella term.
The complexity of Glycogen Storage Disease nomenclature arises from how these conditions were historically discovered. Before modern genetic sequencing allowed us to identify the precise enzymatic defect, clinicians named these disorders after the physicians who first described the clinical presentation. For example, GSD Type I was named "von Gierke disease" after Edgar von Gierke, who published his findings in 1929. As medical science evolved, the field shifted toward classifying Glycogen Storage Disease subtypes by the specific biochemical enzyme missing, which provides a more accurate physiological description of the patient's condition.
Because there are multiple types, patients often encounter a variety of names in their medical records. While Glycogen Storage Disease is the standard clinical term, you may see the following naming conventions:
Major medical databases provide standardized codes to ensure consistency across healthcare systems. In the International Classification of Diseases (ICD-10/11), Glycogen Storage Disease is categorized under "Disorders of carbohydrate metabolism" (E74.0). In the Online Mendelian Inheritance in Man (OMIM) database, each subtype is assigned a unique six-digit number to reflect its distinct genetic etiology. Orphanet, the reference portal for rare diseases, uses the term "Glycogen storage disease" as a parent category (ORPHA:365) to group the individual, rarer subtypes together for research and clinical tracking.
While historical eponymous names remain deeply embedded in clinical practice, modern specialists prefer the GSD classification system (GSD I through GSD XIV). This system is preferred because it is standardized and directly correlates with the genetic and metabolic profile of the patient. For the 379 members of the Glycogen Storage Disease community on DiseaseMaps.org, understanding both the historical name and the formal GSD classification is essential for navigating specialist consultations and accessing clinical trials.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition.